In the present study, delphinidin showed great potential to reduce the cell viability of different NSCLC cells (Figure 2B), also its treatment significantly reduced the phosphorylation of the PI3K/AKT signaling pathways, which are necessary for cell proliferation and survival (Figure 2A). Here, AKT1 is linked to non-small cell lung carcinoma.